Novartis AG (NVS) – Bullish Recovery with Key Levels to WatchAnalysis Overview:
Novartis AG has shown a strong recovery, bouncing back from its recent low near $91.84, a key support level that held well. The stock is now trading at $103.29 (+3.32%), approaching its mid-term moving averages, signaling renewed momentum.
Key Levels:
Support: $91.84 (Strong bas
Compare with Novartis AG Sponsored ADR
5.84 EUR
11.97 B EUR
46.67 B EUR
1.83 B
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Vasant Narasimhan
Website
Headquarters
Basel
Founded
1996
IPO date
May 7, 2001
ISIN
US66987V1098
CUSIP
66987V109
FIGI
BBG00Z0X4R05
Identifiers
ISIN US66987V1098
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateNov 5, 2055
Coupon5.30% (Fixed)
Maturity dateMar 18, 2056
Coupon5.70% (Fixed)
Maturity dateSep 18, 2054
Coupon4.70% (Fixed)
Maturity dateMar 18, 2046
Coupon5.60% (Fixed)
Maturity dateAug 14, 2050
Coupon2.75% (Fixed)
Maturity dateMay 6, 2044
Coupon4.40% (Fixed)
Maturity dateNov 5, 2045
Coupon5.20% (Fixed)
Maturity dateNov 20, 2045
Coupon4.00% (Fixed)
Maturity dateSep 21, 2042
Coupon3.70% (Fixed)
Maturity dateMar 18, 2036
Coupon4.90% (Fixed)
Maturity dateNov 5, 2035
Coupon4.60% (Fixed)
See all NOTA bonds
